“Innovation, inclusion, well-being, gender equity: the key words for attracting and retaining talent” by Editorial Staff AstraZeneca Italia announces that it has received the Top Employer 2024 certification for the tenth consecutive year. The Italian branch of the Anglo-Swedish biopharmaceutical company has distinguished itself among the companies that best guarantee employees quality of the working environment, training opportunities and […]
read more
Italy has become all white, even the Aosta Valley joins the other regions. There will no longer be the obligation to wear the mask outdoors if, however, at a safe distance. What is worrying is the Delta variant which has seen cases quadruple compared to last May. To launch an appeal, today, [...]
read more
According to an ongoing study, vaccines using AstraZeneca and Johnson & Johnson viral vector technology could be associated with rare thrombosis events worldwide. In viral vector vaccines, pharmacologist Antonio Clavenna of the Public Health Department of the Mario Negri Institute in Milan explains to ANSA, "[...]
read more(by Francesco Matera) Palazzo Chigi in these hours is on hot coals between the bubbling square and a vaccination plan that is struggling to start as desired with 600 thousand inoculated doses per day. A strong and credible response to the country is urgently needed which, apparently, will be given at the next CDM scheduled for mid-next [...]
read moreAIFA has decided to extend the ban on the use of the AstraZeneca Covid19 vaccine throughout the country as a precaution and temporarily, pending the rulings of the EMA. This decision was taken in line with similar measures adopted by other European countries Further investigations are currently underway. AIFA, in coordination with [...]
read more
There are 243 admissions to intensive care for Covid-19 in the last 24 hours in Italy, according to data from the Ministry of Health. The daily balance between entries and exits is 100 more patients, bringing the total to exceed 3 again. They are exactly 3.082. The peak of hospitalizations in [...]
read moreFollowing the numerous press interpretations of the last few hours, AIFA specifies that the position of the Technical Scientific Commission has remained unchanged with respect to that expressed in the meeting on Saturday 30 January. Pending further studies, the indication for the AstraZeneca vaccine remains preferentially for the population between 18 and 55 years and without [...]
read moreAIFA authorizes the AstraZeneca vaccine for the prevention of COVID-19 disease in individuals over the age of 18, as per EMA indication. "The arrival of a third vaccine represents an important contribution to the ongoing vaccination campaign", comments AIFA DG Nicola Magrini and "AIFA has provided indications for optimizing the use of existing vaccines [...]
read more
“The advantage of this medicine is that it gives you immediate antibodies - explains Catherine Houlihan, a virologist at University College London Hospital (Uclh). We could tell trial participants who have been exposed: 'yes, you can have the vaccine'. But we cannot assure them that it will protect them from the disease, because it is too late: current vaccines do not confer immunity [...]
read more